KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Novavax (NVAX) over the last 8 years, with Dec 2024 value amounting to $152.2 million.

  • Novavax's Shares Outstanding (Diluted Average) rose 5.09% to $168.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.2 million, marking a year-over-year increase of 5.09%. This contributed to the annual value of $152.2 million for FY2024, which is 51.03% up from last year.
  • As of FY2024, Novavax's Shares Outstanding (Diluted Average) stood at $152.2 million, which was up 51.03% from $100.8 million recorded in FY2023.
  • In the past 5 years, Novavax's Shares Outstanding (Diluted Average) ranged from a high of $152.2 million in FY2024 and a low of $57.6 million during FY2020.
  • Over the past 3 years, Novavax's median Shares Outstanding (Diluted Average) value was $100.8 million (recorded in 2023), while the average stood at $110.4 million.
  • Data for Novavax's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 138.81% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Novavax's Shares Outstanding (Diluted Average) stood at $57.6 million in 2020, then grew by 29.27% to $74.4 million in 2021, then climbed by 5.08% to $78.2 million in 2022, then increased by 28.89% to $100.8 million in 2023, then spiked by 51.03% to $152.2 million in 2024.